Literature DB >> 19162445

Increased pituitary volume in schizophrenia spectrum disorders.

Tsutomu Takahashi1, Michio Suzuki, Dennis Velakoulis, Valentina Lorenzetti, Bridget Soulsby, Shi-Yu Zhou, Kazue Nakamura, Hikaru Seto, Masayoshi Kurachi, Christos Pantelis.   

Abstract

While hypothalamic-pituitary-adrenal (HPA) axis hyperactivity has been implicated in psychotic disorders, previous magnetic resonance imaging (MRI) studies of the pituitary gland volume in schizophrenia have yielded controversial results. It is also unknown whether patients with schizophrenia spectrum such as schizotypal disorder exhibit pituitary volume changes. In this study, we investigated the pituitary volume using MRI in 47 schizotypal disorder patients (29 males, mean age=25.0 years), 72 schizophrenia patients (38 males, mean age=26.2 years), and 81 age and gender matched healthy controls (46 males, mean age=24.5 years). Both patient groups had a larger pituitary volume compared with controls, but no difference was found between the schizophrenia and schizotypal patients. The pituitary volume was larger in females than in males for all diagnostic groups. There was no association between the pituitary volume and type (typical versus atypical), daily dosage, or duration of antipsychotic medication in either patient group. These findings are consistent with a stress-diathesis model of schizophrenia and further suggest that the schizotypal patients share HPA axis hyperactivity with young established schizophrenia patients reflecting a common vulnerability to stress within the schizophrenia spectrum.

Entities:  

Mesh:

Year:  2009        PMID: 19162445     DOI: 10.1016/j.schres.2008.12.016

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  7 in total

Review 1.  Pituitary gland in psychiatric disorders: a review of neuroimaging findings.

Authors:  Murad Atmaca
Journal:  Pituitary       Date:  2014-08       Impact factor: 4.107

Review 2.  Stress and neurodevelopmental processes in the emergence of psychosis.

Authors:  C W Holtzman; H D Trotman; S M Goulding; A T Ryan; A N Macdonald; D I Shapiro; J L Brasfield; E F Walker
Journal:  Neuroscience       Date:  2013-01-05       Impact factor: 3.590

3.  Pituitary volume in schizophrenia spectrum disorders.

Authors:  F Romo-Nava; W S Hoogenboom; P E Pelavin; J L Alvarado; L H Bobrow; F P Macmaster; M Keshavan; R W McCarley; M E Shenton
Journal:  Schizophr Res       Date:  2013-03-19       Impact factor: 4.939

Review 4.  Genetic and Neuroimaging Features of Personality Disorders: State of the Art.

Authors:  Guorong Ma; Hongying Fan; Chanchan Shen; Wei Wang
Journal:  Neurosci Bull       Date:  2016-04-01       Impact factor: 5.203

5.  Pituitary volume in first-episode schizophrenia.

Authors:  Patricia Gruner; Christopher Christian; Delbert G Robinson; Serge Sevy; Handan Gunduz-Bruce; Barbara Napolitano; Robert M Bilder; Philip R Szeszko
Journal:  Psychiatry Res       Date:  2012-08-02       Impact factor: 3.222

6.  Adrenal myelolipoma with hyperandrogenemia and schizophrenia.

Authors:  Ningning Liu; Wenhua Zhang; Jiangshan Tan; Jiaxin Zhou; Xiaopeng Yu; Ningxin Ren; Zhiqing Fang; Wei Jiao; Yidong Fan; Cheng Liu
Journal:  Cancer Manag Res       Date:  2018-02-01       Impact factor: 3.989

7.  Pituitary Volume and Socio-Cognitive Functions in Individuals at Risk of Psychosis and Patients With Schizophrenia.

Authors:  Tsutomu Takahashi; Yuko Higuchi; Yuko Komori; Shimako Nishiyama; Yoichiro Takayanagi; Daiki Sasabayashi; Mikio Kido; Atsushi Furuichi; Yumiko Nishikawa; Mihoko Nakamura; Kyo Noguchi; Michio Suzuki
Journal:  Front Psychiatry       Date:  2018-11-09       Impact factor: 4.157

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.